Human CD300C delivers an Fc receptor-γ-dependent activating signal in mast cells and monocytes and differs from CD300A in ligand recognition

Journal of Biological Chemistry

Volumn 288, Issue 11, 2013, Pages 7662-7675

  Takahashi, Mariko ^a   Izawa, Kumi ^a   Kashiwakura, Jun Ichi ^b,c   Yamanishi, Yoshinori ^a   Enomoto, Yutaka ^a   Kaitani, Ayako ^a   Maehara, Akie ^a   Isobe, Masamichi ^a   Ito, Shinichi ^a   Matsukawa, Toshihiro ^a   Nakahara, Fumio ^a   Oki, Toshihiko ^a   Kajikawa, Masunori ^d   Ra, Chisei ^b   Okayama, Yoshimichi ^b   Kitamura, Toshio ^a   Kitaura, Jiro ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b NIHON UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c Institute of Physical and Chemical Research   (Japan)

^d ACTGen Inc   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATING FUNCTION; AMINO ACID RESIDUES; CYTOKINE PRODUCTION; EFFICIENT SURFACE; IMMUNOGLOBULIN-LIKE DOMAINS; LIGAND RECOGNITION; PHOSPHATIDYLETHANOLAMINE; REPORTER CELL LINE;

AMINO ACIDS; ANTIBODIES; CELL CULTURE; CHEMICAL ACTIVATION; ENZYME ACTIVITY; LIGANDS; MACROPHAGES;

BODY FLUIDS;

ANTIBODY; CD300A ANTIBODY; CD300A PROTEIN; CD300C ANTIBODY; CD300C PROTEIN; FC RECEPTOR; GREEN FLUORESCENT PROTEIN; PHOSPHATIDYLETHANOLAMINE; RECEPTOR; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ANIMAL CELL; ARTICLE; CELL STIMULATION; CONTROLLED STUDY; INTRACELLULAR SIGNALING; LEUKOCYTE ACTIVATION; MAST CELL; MOLECULAR RECOGNITION; MONOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION;

ANIMALS; ANTIGENS, SURFACE; CYTOKINES; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION REGULATION; HL-60 CELLS; HUMANS; IMMUNE SYSTEM; JURKAT CELLS; K562 CELLS; LIGANDS; MAST CELLS; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED C57BL; MONOCYTES; NIH 3T3 CELLS; PHAGOCYTOSIS; RATS; RECEPTORS, IGG; SIGNAL TRANSDUCTION; STRUCTURE-ACTIVITY RELATIONSHIP; U937 CELLS;

EID: 84875160229     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M112.434746     Document Type: Article

References (51)

1. Clark, G. J., Ju, X., Tate, C., and Hart, D. N. (2009) The CD300 family of molecules are evolutionarily significant regulators of leukocyte functions. Trends Immunol. 30, 209-217
2. Klesney-Tait, J., Turnbull, I. R., and Colonna, M. (2006) The TREM receptor family and signal integration. Nat. Immunol. 7, 1266-1273
3. Ivashkiv, L. B. (2009) Cross-regulation of signaling by ITAM-associated receptors. Nat. Immunol. 10, 340-347
4. Blank, U., Launay, P., Benhamou, M., and Monteiro, R. C. (2009) Inhibitory ITAMs as novel regulators of immunity. Immunol. Rev. 232, 59-71
5. Ravetch, J. V., and Lanier L. L. (2000) Immune inhibitory receptors. Science 290, 84-89
6. Kumagai, H., Oki, T., Tamitsu, K., Feng, S. Z., Ono, M., Nakajima, H., Bao, Y. C., Kawakami, Y., Nagayoshi, K., Copeland, N. G., Gilbert, D. J., Jenkins, N. A., Kawakami, T., and Kitamura, T. (2003) Identification and characterization of a new pair of immunoglobulin-like receptors LMIR1 and 2 derived from murine bone marrow derived mast cells. Biochem. Biophys. Res. Commun. 307, 719-729
7. Izawa, K., Kitaura, J., Yamanishi, Y., Matsuoka, T., Oki, T., Shibata, F., Kumagai, H., Nakajima, H., Maeda-Yamamoto, M., Hauchins, J. P., Tybulewicz, V. L., Takai, T., and Kitamura, T. (2007) Functional analysis of activating receptor LMIR4 as a counterpart of inhibitory receptor LMIR3. J. Biol. Chem. 282, 17997-18008
8. Yamanishi, Y., Kitaura, J., Izawa, K., Matsuoka, T., Oki, T., Lu, Y., Shibata, F., Yamazaki, S., Kumagai, H., Nakajima, H., Maeda-Yamamoto, M., Tybulewicz, V. L., Takai, T., and Kitamura, T. (2008) Analysis of mouse LMIR5/CLM-7 as an activating receptor. Differential regulation of LMIR5/CLM-7 in mouse versus human cells. Blood 111, 688-698
9. Enomoto, Y., Yamanishi, Y., Izawa, K., Kaitani, A., Takahashi, M., Maehara, A., Oki, T., Takamatsu, R., Kajikawa, M., Takai, T., Kitamura, T., and Kitaura, J. (2010) Characterization of leukocyte mono-immunoglobulinlike receptor 7 (LMIR7)/CLM-3 as an activating receptor. Its similarities to and differences from LMIR4/CLM-5. J. Biol. Chem. 285, 35274-35283
10. Izawa, K., Kitaura, J., Yamanishi, Y., Matsuoka, T., Kaitani, A., Sugiuchi, M., Takahashi, M., Maehara, A., Enomoto, Y., Oki, T., Takai, T., and Kitamura, T. (2009) An activating and inhibitory signal from an inhibitory receptor LMIR3/CLM-1. LMIR3 augments lipopolysaccharide response through association with FcRγ in mast cells. J. Immunol. 183, 925-936
11. Chung, D. H., Humphrey, M. B., Nakamura, M. C., Ginzinger, D. G., Seaman, W. E., and Daws, M. R. (2003) CMRF-35-like molecule-1, a novel mouse myeloid receptor, can inhibit osteoclast formation. J. Immunol. 171, 6541-6548
12. Yotsumoto, K., Okoshi, Y., Shibuya, K., Yamazaki, S., Tahara-Hanaoka, S., Honda, S., Osawa, M., Kuroiwa, A., Matsuda, Y., Tenen, D. G., Iwama, A., Nakauchi, H., and Shibuya, A. (2003) Paired activating and inhibitory immunoglobulin-like receptors, MAIR-I and MAIR-II, regulate mast cell and macrophage activation. J. Exp. Med. 198, 223-233
13. Alvarez-Errico, D., Aguilar, H., Kitzig, F., Brckalo, T., Sayós, J., and López-Botet, M. (2004) IREM-1 is a novel inhibitory receptor expressed by myeloid cells. Eur. J. Immunol. 34, 3690-3701
14. Aguilar, H., Alvarez-Errico, D., García-Montero, A. C., Orfao, A., Sayós, J., and López-Botet, M. (2004) Molecular characterization of a novel immune receptor restricted to the monocytic lineage. J. Immunol. 173, 6703-6711
15. Martínez-Barriocanal, A., Comas-Casellas, E., Schwartz, S., Jr., Martín, M., and Sayós, J. (2010) CD300 heterocomplexes, a new and family-restricted mechanism for myeloid cell signaling regulation. J. Biol. Chem. 285, 41781-41794
16. Lankry, D., Simic, H., Klieger, Y., Levi-Schaffer, F., Jonjic, S., and Mandelboim, O. (2010) Expression and function of CD300 in NK cells. J. Immunol. 185, 2877-2886
17. Ju, X., Zenke, M., Hart, D. N., and Clark, G. J. (2008) CD300a/c regulate type I interferon and TNF-α secretion by human plasmacytoid dendritic cells stimulated with TLR7 and TLR9 ligands. Blood 112, 1184-1194
18. Alvarez, Y., Tang, X., Coligan, J. E., and Borrego, F. (2008) The CD300a (IRp60) inhibitory receptor is rapidly up-regulated on human neutrophils in response to inflammatory stimuli and modulates CD32a (FcγRIIa) mediated signaling. Mol. Immunol. 45, 253-258
19. Bachelet, I., Munitz, A., Moretta, A., Moretta, L., and Levi-Schaffer, F. (2005) The inhibitory receptor IRp60 (CD300a) is expressed and functional on human mast cells. J. Immunol. 175, 7989-7995
20. Narayanan, S., Silva, R., Peruzzi, G., Alvarez, Y., Simhadri, V. R., Debell, K., Coligan, J. E., and Borrego, F. (2010) Human Th1 cells that express CD300a are polyfunctional and after stimulation up-regulate the T-box transcription factor eomesodermin. PLoS One 5, e10636
21. Cantoni, C., Bottino, C., Augugliaro, R., Morelli, L., Marcenaro, E., Castriconi, R., Vitale, M., Pende, D., Sivori, S., Millo, R., Biassoni, R., Moretta, L., and Moretta, A. (1999) Molecular and functional characterization of IRp60, a member of the immunoglobulin superfamily that functions as an inhibitory receptor in human NK cells. Eur. J. Immunol. 29, 3148-3159
22. Silva, R., Moir, S., Kardava, L., Debell, K., Simhadri, V. R., Ferrando-Martínez, S., Leal, M., Peña, J., Coligan, J. E., and Borrego, F. (2011) CD300a is expressed on human B cells, modulates BCR mediated signaling, and its expression is downregulated in HIV infection. Blood 117, 5870-5880
23. Munitz, A., Bachelet, I., Eliashar, R., Moretta, A., Moretta, L., and Levi-Schaffer, F. (2006) The inhibitory receptor IRp60 (CD300a) suppresses the effects of IL-5, GM-CSF, and eotaxin on human peripheral blood eosinophils. Blood 107, 1996-2003
24. Munitz, A., Bachelet, I., and Levi-Schaffer, F. (2006) Reversal of airway inflammation and remodeling in asthma by a bispecific antibody fragment linking CCR3 to CD300a. J. Allergy Clin. Immunol. 118, 1082-1089
25. Bachelet, I., Munitz, A., and Levi-Schaffer, F. (2006) Abrogation of allergic reactions by a bispecific antibody fragment linking IgE to CD300a. J. Allergy Clin. Immunol. 117, 1314-1320
26. Yamanishi, Y., Kitaura, J., Izawa, K., Kaitani, A., Komeno, Y., Nakamura, M., Yamazaki, S., Enomoto, Y., Oki, T., Akiba, H., Abe, T., Komori, T., Morikawa, Y., Kiyonari, H., Takai, T., Okumura, K., and Kitamura, T. (2010) TIM1 is an endogenous ligand for LMIR5/CD300b. LMIR5 deficiency ameliorates mouse kidney ischemia/reperfusion injury. J. Exp. Med. 207, 1501-1511
27. Nakahashi-Oda, C., Tahara-Hanaoka, S., Honda, S., Shibuya, K., and Shibuya, A. (2012) Identification of phosphatidylserine as a ligand for the CD300a immunoreceptor. Biochem. Biophys. Res. Commun. 417, 646-650
28. Nakahashi-Oda, C., Tahara-Hanaoka, S., Shoji, M., Okoshi, Y., Nakano-Yokomizo, T., Ohkohchi, N., Yasui, T., Kikutani, H., Honda, S., Shibuya, K., Nagata, S., and Shibuya, A. (2012) Apoptotic cells suppress mast cell inflammatory responses via the CD300a immunoreceptor. J. Exp. Med. 209, 1493-1503
29. Simhadri, V. R., Andersen, J. F., Calvo, E., Choi, S. C., Coligan, J. E., and Borrego, F. (2012) Human CD300a binds to phosphatidylethanolamine and phosphatidylserine, and modulates the phagocytosis of dead cells. Blood 119, 2799-2809
30. Izawa, K., Yamanishi, Y., Maehara, A., Takahashi, M., Isobe, M., Ito, S., Kaitani, A., Matsukawa, T., Matsuoka, T., Nakahara, F., Oki, T., Kiyonari, H., Abe, T., Okumura, K., Kitamura, T., and Kitaura, J. (2012) The receptor LMIR3 negatively regulates mast cell activation and allergic responses by binding to extracellular ceramide. Immunity 37, 827-839
31. Ohtsuka, M., Arase, H., Takeuchi, A., Yamasaki, S., Shiina, R., Suenaga, T., Sakurai, D., Yokosuka, T., Arase, N., Iwashima, M., Kitamura, T., Moriya, H., and Saito, T. (2004) NFAM1, an immunoreceptor tyrosine-based activation motif-bearing molecule that regulates B cell development and signaling. Proc. Natl. Acad. Sci. U.S.A. 101, 8126-8131
32. Yamasaki, S., Ishikawa, E., Sakuma, M., Hara, H., Ogata, K., and Saito, T. (2008) Mincle is an ITAM-coupled activating receptor that senses damaged cells. Nat. Immunol. 9, 1179-1188
33. Takai, T., Li, M., Sylvestre, D., Clynes, R., and Ravetch, J. V. (1994) FcRγ chain deletion results in pleiotrophic effector cell defects. Cell 76, 519-529
34. Kitaura, J., Song, J., Tsai, M., Asai, K., Maeda-Yamamoto, M., Mocsai, A., Kawakami, Y., Liu, F. T., Lowell, C. A., Barisas, B. G., Galli, S. J., and Kawakami, T. (2003) Evidence that IgE molecules mediate a spectrum of effects on mast cell survival and activation via aggregation of the FcεRI. Proc. Natl. Acad. Sci. U.S.A. 100, 12911-12916
35. Lu, Y., Kitaura, J., Oki, T., Komeno, Y., Ozaki, K., Kiyono, M., Kumagai, H., Nakajima, H., Nosaka, T., Aburatani, H., and Kitamura, T. (2007) Identification of TSC-22 as a potential tumor suppressor that is upregulated by Flt3-D835V but not Flt3-ITD. Leukemia 21, 2246-2257
36. Okumura, S., Kashiwakura, J., Tomita, H., Matsumoto, K., Nakajima, T., Saito, H., and Okayama, Y. (2003) Identification of specific gene expression profiles in human mast cells mediated by Toll-like receptor 4 and FcεRI. Blood 102, 2547-2554
37. Verreck, F. A., de Boer, T., Langenberg, D. M., Hoeve, M. A., Kramer, M., Vaisberg, E., Kastelein, R., Kolk, A., de Waal-Malefyt, R., and Ottenhoff, T. H. (2004) Human IL-23-producing type 1 macrophages promote but IL-10-producing type 2 macrophages subvert immunity to (myco)bacteria. Proc. Natl. Acad. Sci. U.S.A. 101, 4560-4565
38. Shiratori, I., Ogasawara, K., Saito, T., Lanier, L. L., and Arase, H. (2004) Activation of natural killer cells and dendritic cells upon recognition of a novel CD99-like ligand by paired immunoglobulin-like type 2 receptor. J. Exp. Med. 199, 525-533
39. Kitamura, T., Koshino, Y., Shibata, F., Oki, T., Nakajima, H., Nosaka, T., and Kumagai, H. (2003) Retrovirus-mediated gene transfer and expression cloning. Powerful tools in functional genomics. Exp. Hematol. 31, 1007-1014
40. Kato, N., Kitaura, J., Doki, N., Komeno, Y., Watanabe-Okochi, N., Togami, K., Nakahara, F., Oki, T., Enomoto, Y., Fukuchi, Y., Nakajima, H., Harada, Y., Harada, H., and Kitamura, T. (2011) Two types of C/EBPα mutations play distinct but collaborative roles in leukemogenesis. Lessons from clinical data and BMT models. Blood 117, 221-233
41. Morita, S., Kojima, T., and Kitamura, T. (2000) Plat-E. An efficient and stable system for transient packaging of retroviruses. Gene Ther. 7, 1063-1066
42. Kobayashi, N., Karisola, P., Peña-Cruz, V., Dorfman, D. M., Jinushi, M., Umetsu, S. E., Butte, M. J., Nagumo, H., Chernova, I., Zhu, B., Sharpe, A. H., Ito, S., Dranoff, G., Kaplan, G. G., Casasnovas, J. M., Umetsu, D. T., Dekruyff, R. H., and Freeman, G. J. (2007) TIM-1 and TIM-4 glycoproteins bind phosphatidylserine and mediate uptake of apoptotic cells. Immunity 27, 927-940
43. Miyanishi, M., Tada, K., Koike, M., Uchiyama, Y., Kitamura, T., and Nagata, S. (2007) Identification of Tim4 as a phosphatidylserine receptor. Nature 450, 435-439
44. Comas-Casellas, E., Martínez-Barriocanal, Á., Miró, F., Ejarque-Ortiz, A., Schwartz, S., Jr., Martín, M., and Sayós, J. (2012) Cloning and characterization of CD300d, a novel member of the human CD300 family of immune receptors. J. Biol. Chem. 287, 9682-9693
45. Bouchon, A., Dietrich, J., and Colonna, M. (2000) Cutting edge. Inflammatory responses can be triggered by TREM-1, a novel receptor expressed on neutrophils and monocytes. J. Immunol. 164, 4991-4995
46. Balasubramanian, K., and Schroit, A. J. (2003) Aminophospholipid asymmetry. A matter of life and death. Annu. Rev. Physiol. 65, 701-734
47. Ravichandran, K. S. (2010) Find-me and eat-me signals in apoptotic cell clearance. Progress and conundrums. J. Exp. Med. 207, 1807-1817
48. Emoto, K., Toyama-Sorimachi, N., Karasuyama, H., Inoue, K., and Umeda, M. (1997) Exposure of phosphatidylethanolamine on the surface of apoptotic cells. Exp. Cell Res. 232, 430-434
49. Vance, J. E. (2008) Phosphatidylserine and phosphatidylethanolamine in mammalian cells. Two metabolically related aminophospholipids. J. Lipid Res. 49, 1377-1387
50. Nagata, S., Hanayama, R., and Kawane, K. (2010) Autoimmunity and the clearance of dead cells. Cell 140, 619-630
51. Cannon, J. P., O'Driscoll, M., and Litman, G. W. (2012) Specific lipid recognition is a general feature of CD300 and TREM molecules. Immunogenetics 64, 39-47